Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.03 USD
Change Today -0.375 / -5.85%
Volume 1.2M
PGNX On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - progenics pharmaceuticals (PGNX)

NameBoard RelationshipsTitleAge
Mark R. Baker J.D.25 RelationshipsChief Executive Officer, Director and Member of Science & Strategy Committee59
Paul J. Maddon M.D., Ph.D.41 RelationshipsFounder, Vice Chairman and Chairman of Nominating & Corporate Governance Committee54
Angelo William Lovallo Jr.No RelationshipsPrincipal Financial Officer, Principal Accounting Officer, Vice President of Finance and Treasurer49
John W. Babich Ph.D.No RelationshipsSenior Vice President57
Robert J. Israel M.D.No RelationshipsExecutive Vice President of Medical Affairs57

Board Members - progenics pharmaceuticals (PGNX)

NameBoard RelationshipsPrimary CompanyAge
Peter J. Crowley 87 RelationshipsMTS Health Partners, L.P.55
Mark R. Baker J.D.25 RelationshipsProgenics Pharmaceuticals, Inc.59
Paul J. Maddon M.D., Ph.D.41 RelationshipsProgenics Pharmaceuticals, Inc.54
Stephen P. Goff Ph.D.60 RelationshipsProgenics Pharmaceuticals, Inc.62
David A. Scheinberg M.D., Ph.D.61 RelationshipsProgenics Pharmaceuticals, Inc.58

Executive Committees* - progenics pharmaceuticals (PGNX)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeNicole S. Williams M.B.A. 36 Relationships3 Executives
Compensation CommitteePeter J. Crowley 87 Relationships2 Executives
Nominating CommitteePaul J. Maddon M.D., Ph.D. 41 Relationships2 Executives
Corporate Governance CommitteePaul J. Maddon M.D., Ph.D. 41 Relationships2 Executives
Advisory BoardStephen P. Goff Ph.D. 60 Relationships13 Executives
View PGNX Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $6.03 USD -0.375

PGNX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CTI BioPharma Corp $1.96 USD +0.01
Genocea Biosciences Inc $12.24 USD -0.26
Inovio Pharmaceuticals Inc $10.35 USD -0.25
Peregrine Pharmaceuticals Inc $1.39 USD -0.045
Rigel Pharmaceuticals Inc $4.88 USD +0.55
View Industry Companies
 

Industry Analysis

PGNX

Industry Average

Valuation PGNX Industry Range
Price/Earnings 99.1x
Price/Sales 10.0x
Price/Book 3.6x
Price/Cash Flow 90.0x
TEV/Sales 7.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.